ENDRA Life Sciences Inc (NDRA)

NASDAQ
4.129
-0.101(-2.39%)
  • Volume:
    2,727
  • Day's Range:
    3.950 - 4.145
  • 52 wk Range:
    3.159 - 13.000

NDRA Overview

Prev. Close
4.05
Day's Range
3.95-4.145
Revenue
-
Open
4.07
52 wk Range
3.159-13
EPS
-4.94
Volume
2,727
Market Cap
13.04M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
25,445
P/E Ratio
-0.82
Beta
0.947
1-Year Change
-68.36%
Shares Outstanding
3,158,722
Next Earnings Date
21 Mar 2023
What is your sentiment on ENDRA Life Sciences?
or
Vote to see community's results!

ENDRA Life Sciences Inc News

ENDRA Life Sciences Inc Analysis

ENDRA Life Sciences Inc Company Profile

ENDRA Life Sciences Inc Company Profile

ENDRA Life Sciences Inc. develops technology for increasing the capabilities of clinical diagnostic ultrasound to broaden patient access to the diagnosis and treatment of various medical conditions in circumstances where other diagnostic technologies are unavailable or impractical. The Company has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and stage progression of non-alcoholic fatty liver disease (NAFLD), which untreated, can progress to Non-alcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The Company's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Read More

Analyst Price Target

Average92.500 (+2,140.252% Upside)
High100.000
Low85.000
Price4.129
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsSellNeutralSellStrong SellStrong Sell
SummarySellNeutralSellStrong SellStrong Sell